Skip to content

CG Oncology, Inc.

CGON

CIK 0001991792

← back to feed
Revenue (TTM)
$2.8M
+254.7% YoY Q1 May 2026
Net Income (TTM)
−$179.89M
−82.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.27
−47.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-7,442.4%
Q1 May 2026
Net Margin
-6,422.3%
Q1 May 2026
Free Cash Flow (TTM)
−$120.35M
Q1 May 2026
Cash
$33.7M
Q1 May 2026
Total Debt
$3M
Q1 May 2026
Shares Outstanding
88.2M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings